Watch Newsy On TV

FDA Approves New Drug To Stop Migraines Before They Start

SMS
FDA Approves New Drug To Stop Migraines Before They Start
It's called Aimovig, and it's the first FDA-approved preventive migraine treatment in a new class of drugs.
SHOW TRANSCRIPT

The U.S. Food and Drug Administration approved a new drug Thursday that's been shown to stop migraines before they begin.

It's called Aimovig, and it's the first FDA-approved preventive migraine treatment in a new class of drugs. It works by blocking a molecule that's believed to be involved in migraine attacks. 

Users inject themselves with the medication once a month with a device that resembles an insulin pen.

And experts say it could be a game changer for the millions of people who suffer from migraines.

As one migraine specialist told The New York Times: "The drugs will have a huge impact. This is really an amazing time for my patient population and for general neurologists treating patients with migraine."

Aimovig is expected to be available to patients within a week. The U.S. list price for the drug is $575 per month, or $6,900 per year.

But as NBC notes, the FDA's seal of approval means the drug could be available with a prescription soon, and health insurance could help shoulder the cost.